Institute For Evolvable Medicines

Oakland, CA

UEI
W9DGN9JRK8R8
CAGE
9ZXR6
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Non-Profit Organization
Entity structure
Corporate Entity (Tax Exempt)
SAM.gov registration date
Physical address
11 Embarcadero West STE 140, Oakland, CA 94607, USA
Website
evorx.org
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
80 Health Services

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Phase 1 clinical trial for therapeutic intervention particles (tips). W81XWH2110875 Defense Health Agency $4,499,999

Quick answers

Is Institute For Evolvable Medicines registered in SAM.gov?

Yes. Institute For Evolvable Medicines's SAM.gov registration is active through July 8, 2027.

What is Institute For Evolvable Medicines's most recent federal award?

Institute For Evolvable Medicines's most recent federal grant award is Phase 1 clinical trial for therapeutic intervention particles (tips) (W81XWH2110875), from Defense Health Agency, on September 30, 2021.

On GovTribe

See Institute For Evolvable Medicines's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors